Welcome to the EU Policy Corner
Liver disease is estimated to affect 6% of the EU's population (approx. 29 million people) and is reported to be the EU's 5th biggest killer, accounting for at least one in six deaths. Despite such alarming statistics, liver disease is still widely neglected by the EU. EASL believes the EU has a key role to play in raising awareness of liver disease in Europe, increasing additional funding for research, setting standards and guidelines for the prevention, diagnosis, treatment and care of liver disease across the EU and encourage member states to make liver disease a public health and research priority.
This is why we are working to push this agenda forward in Brussels, the heart of EU policy-making, in a myriad of policy areas relevant to liver disease, including: public health, research, communicable diseases, nutrition and obesity, alcohol, organ donation and transplantation, cancer and rare diseases.
The EU Policy corner provides you with an overview of our advocacy activities in this range of policy issues and tries to clarify what EU funding opportunities are available to you.
For more information about EASL advocacy activities in Brussels, please contact:
We thank our Premium Sponsors for their generous contributions and support of the EU Framework project application support programme.
You can click here to access the monothematic conference 10-12 December in Athens, Greece.
Below is a video clip of Mark Thursz, EASL Vice-Secretary, discussing the resolution to viral hepatitis discussed by the World Health Assembly in Geneva on 17th May 2010.